Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06217666
Title Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC)
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Haoming (Carl) Qiu
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.